SEC Comment Letter for Whitehawk Therapeutics, Inc. (WHWK) (CIK 0001422142) (WHWK) — Feb 11, 2019
Whitehawk Therapeutics, Inc. (WHWK) (CIK 0001422142)
Date: Feb. 11, 2019 · CIK: 0001422142 · Accession: 0000000000-19-001711
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229087
Letter
February 7, 2019 Stephen Hoffman Chief Executive Officer Aerpio Pharmaceuticals, Inc. 9987 Carver Road Cincinnati, OH 45242 Re:Aerpio Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed December 28, 2018 File No. 333-229087 Dear Mr. Hoffman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Todd Schiffman at 202-551-3491 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
February 7, 2019
Stephen Hoffman
Chief Executive Officer
Aerpio Pharmaceuticals, Inc.
9987 Carver Road
Cincinnati, OH 45242
Re:Aerpio Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed December 28, 2018
File No. 333-229087
Dear Mr. Hoffman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Todd Schiffman at 202-551-3491 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance